Public Profile

LTS Lohmann Therapie-Systeme AG

LTS Lohmann Therapie-Systeme AG, commonly referred to as LTS, is a leading global player in the pharmaceutical and medical device industry, headquartered in Andernach, Germany. Founded in 1981, the company has established itself as a pioneer in transdermal drug delivery systems, offering innovative solutions that enhance patient compliance and therapeutic efficacy. With a strong presence in Europe, North America, and Asia, LTS focuses on the development and manufacturing of advanced drug delivery technologies, including patches and films. Their unique approach combines cutting-edge research with state-of-the-art production capabilities, ensuring high-quality products tailored to meet diverse medical needs. Recognised for its commitment to excellence, LTS has achieved significant milestones, solidifying its market position as a trusted partner for pharmaceutical companies worldwide.

DitchCarbon Score

How does LTS Lohmann Therapie-Systeme AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

10

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

LTS Lohmann Therapie-Systeme AG's score of 10 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.

75%

LTS Lohmann Therapie-Systeme AG's reported carbon emissions

LTS Lohmann Therapie-Systeme AG, headquartered in Germany, currently does not have available carbon emissions data for the most recent year, nor specific reduction targets or climate commitments outlined in their initiatives. Without concrete figures or defined goals, it is challenging to assess their carbon footprint or climate strategy. However, the company may still be engaged in broader industry efforts to address climate change, aligning with global sustainability trends. As the landscape of corporate climate action evolves, it is essential for companies like LTS to establish measurable targets and transparent reporting to contribute effectively to climate mitigation efforts.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. LTS Lohmann Therapie-Systeme AG's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. LTS Lohmann Therapie-Systeme AG is headquartered in DE, which has a rank of medium, indicating medium grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

LTS Lohmann Therapie-Systeme AG is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

BioDelivery Sciences International, Inc.

US
Chemicals nec
Updated 5 days ago
DitchCarbon Score

Arx LLC

US
Chemicals nec
Updated 2 days ago

Aquestive Therapeutics, Inc.

US
Chemicals nec
Updated 5 days ago

Lonza

CH
Furniture; other manufactured goods n.e.c. (36)
Updated about 8 hours ago

Collegium Pharmaceutical, Inc.

US
Chemicals nec
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers